Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?
1 November 2011
Because health care resources always are scarce, decisions about what (and what not) to pay for cannot be avoided. Deciding how to value health and aspects of…
Is the Aim of the Health Care System to Maximise QALYs? An Investigation of
1 May 2011
The appraisal of health care technologies by the UK’s National Institute for Health and Clinical Excellent (NICE) focuses on cost effectiveness, usually measured in terms of…
Incorporating Multiple Criteria in HTA: Methods and Processes
1 March 2011
What a health care system should pay for depends, of course, on the health gain that results. Health technology assessment (HTA) and cost-effectiveness analysis have become…
Disease severity and public preferences
4 November 2010
Does including the name of a specific severe disease in preference surveys affect public attitudes toward resource allocation? A recent proof of concept study suggests that…
Value Based Pricing in the UK
7 September 2010
Every country around the globe struggles with attaining an appropriate balance between providing affordable health care and ensuring access to medical advances. In a recent article…
Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
1 November 2010
In December 2006, the National Institute for Health and Clinical Excellence (NICE) issued guidance for preventing and managing overweight and obesit. Recommendations are step-wise, starting with…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and…
Using QALYs in Cancer: Review of the Methodological Limitations
1 October 2010
Current methods for constructing quality adjusted life year (QALY) measurements may be deficient for cancer patients in three respects: descriptions of health state, valuation of health…